SyntekaBio,Inc. Logo

SyntekaBio,Inc.

AI drug discovery platform accelerating R&D with supercomputing, SaaS, and pre-made candidates.

226330 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학17로 18 -, 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure to accelerate the development of therapeutics. The company's core platform, DeepMatcher®, automates the process of identifying and optimizing drug candidates from hit screening to preclinical lead generation. SyntekaBio offers its technology through several business models: STB LaunchPad, a repository of pre-made, 'off-the-shelf' drug candidates for over 100 disease targets; end-to-end discovery and development services; and a suite of CLOUD-SaaS modules for specific applications like small molecule analysis (Sm-ARS), neoantigen prediction (NEO-ARS), and antibody design (Ab-ARS). This 'factory-like' approach aims to reduce the time and cost of pharmaceutical R&D for its partners.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SyntekaBio,Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.1 KB
2025-09-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB
2025-09-12 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 85.9 KB
2025-09-12 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-09-12 00:00
Capital/Financing Update
단기차입금감소결정(자율공시)
Korean 7.0 KB
2025-09-12 00:00
Major Shareholding Notification
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Korean 12.4 KB
2025-09-12 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 30.4 KB
2025-09-12 00:00
Registration Form
증권신고서(지분증권) (2025.12)
Korean 2.4 MB
2025-09-03 00:00
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
Korean 79.9 KB
2025-09-03 00:00
Capital/Financing Update
단기차입금증가결정
Korean 9.1 KB

Automate Your Workflow. Get a real-time feed of all SyntekaBio,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SyntekaBio,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America 950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea 115180
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan 6098
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889

Talk to a Data Expert

Have a question? We'll get back to you promptly.